Healius Limited (ASX:HLS)
0.3250
+0.0050 (1.56%)
Jun 5, 2026, 4:10 PM AEST
Healius Market Cap
Healius has a market cap or net worth of 235.99 million as of June 5, 2026. Its market cap has decreased by -63.28% in one year.
Market Cap
235.99M
Enterprise Value
1.12B
Revenue
1.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
0.33
Market Cap Chart
Since August 29, 2000, Healius's market cap has decreased from 478.57M to 235.99M, a decrease of -50.69%. That is a compound annual growth rate of -2.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 235.99M | -64.09% |
| Dec 31, 2025 | 657.15M | -33.94% |
| Dec 31, 2024 | 994.80M | -16.20% |
| Dec 29, 2023 | 1.19B | -32.22% |
| Dec 30, 2022 | 1.75B | -43.13% |
| Dec 31, 2021 | 3.08B | 32.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 771.05M |
| Australian Clinical Labs | 384.10M |
| Monash IVF Group | 270.80M |
| Cryosite | 51.74M |
| INOVIQ | 47.86M |
| Microba Life Sciences | 38.36M |
| Rhythm Biosciences | 37.16M |
| BCAL Diagnostics | 27.28M |